streptococcus oralis
Cell therapyexperimental
Streptococcus oralis is a Gram positive viridans streptococcus of the Streptococcus mitis group. S. oralis is one of the pioneer species associated with eubiotic dental pellicle biofilms, and can be found in high numbers on most oral surfaces. It has been, however, found to be an opportunistic pathogen as well. — Wikipedia
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Mar 1, 2018 (NCT03449836)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- microbiotaTissue restoration
microbiota tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaStreptococcus oralis ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03449836 | Phase 3 | Mar 1, 2018 | University of Naples Frederico II |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Naples Frederico II | Academic/Hospital | 1 | 1 | 1 | 2018 |
1 organizations
Page 1 / 1